Hand Dermatitis Clinical Trials

A listing of Hand Dermatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatitis.

corticosteroids
atopy
baricitinib
ly3009104
eczema
  • 103 views
  • 31 Jul, 2021
  • 190 locations
Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

This is a research study to determine the efficacy and safety of investigational drug MEDI3506 for the treatment of adult subjects with Atopic Dermatitis.

atopy
body mass index
topical agents
  • 182 views
  • 27 Jul, 2021
  • 58 locations
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

This 110-week study is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis.

atopy
eczema
progestogen
hormonal contraception
topical agents
  • 154 views
  • 26 Jul, 2021
  • 347 locations
Seal Stopping Eczema and Allergy Study

This is a randomized, controlled trial designed for children who are have already developed atopic dermatitis (AD or eczema) by 10 weeks of age. The aim is to compare the effect of proactive sequential skin care, including the twice-daily use of a tri-lipid skin barrier cream (Epiceram) or moisturizer and …

eczema
epiceram
dry skin
topical agents
food allergy
  • 0 views
  • 19 Jul, 2021
  • 3 locations
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

The purpose of this study is to evaluate the effectiveness and safety of 3 dose regimen of CC-93538 in adult participants with moderate to severe Atopic Dermatitis (AD).

corticosteroids
montelukast
ultraviolet light
topical agents
asthma
  • 0 views
  • 25 Jul, 2021
  • 85 locations
Crisaborole for Chinese and Japanese Subjects ( 2 Years of Age) With Mild to Moderate Atopic Dermatitis

This study is a phase 3, randomized, double blind and vehicle study to evaluate the efficacy and safety of Crisaborole ointment, 2% in Chinese and Japanese subjects with mild to moderate atopic dermatitis involving at least 5% treatable BSA. Eligible subjects will be randomized in a 2:1 ratio to one …

atopy
crisaborole ointment
crisaborole
  • 7 views
  • 25 Jul, 2021
  • 49 locations
A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients

A Phase I/IIa Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GM-XANTHO in Healthy Volunteers and to Investigate its Efficacy and Safety Profile in Atopic Dermatitis Patients

corticosteroids
platelet count
eczema
hormonal contraception
blood test
  • 0 views
  • 26 Jul, 2021
  • 1 location
A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

The reason for this study is to assess the impact of lebrikizumab on vaccine immune response in adult participants with moderate to severe atopic dermatitis (AD).

eczema
topical agents
lebrikizumab
  • 0 views
  • 24 Jul, 2021
  • 90 locations
A Study to Test the Safety Pharmacokinetics and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

The purpose of the study is to investigate the safety and tolerability of single-ascending doses of UCB9741 administered by intravenous infusion or subcutaneous injection to healthy study participants and following repeat dosing at a single dose level in study participants with atopic dermatitis. Furthermore, the clinical outcome in study participants …

eczema
body mass index
  • 0 views
  • 20 Jul, 2021
  • 1 location
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis

This open-label study will evaluate the long-term efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis (AD).

eczema
baricitinib
ly3009104
topical agents
  • 0 views
  • 25 Jul, 2021
  • 76 locations